Muriel Wood

BioSynchronicity Corp. is a company that specializes in developing state-of-the-art diagnostic testing solutions for present and future healthcare needs. The company is based in Rochester, NY and was founded in 2020 by Bharat Kris Rao and Muriel Wood. The company's innovative diagnostic test system is designed to detect infection from emergent viruses and is manufactured under ISO-13485 certified protocols with superior risk mitigation protocols, supervision, and process oversight. The company offers professional use boxes with 20 tests per box, and packaging can be customized in appropriate languages and include symbols or certification required by local regulatory bodies. The MENA and African markets will be serviced from Ras Al Khaimah. The company has received an FDA pre-emergency use authorization (pre-EUA) number in May 2021 and is in the final stage of completing their submission required for the full EUA approval. The company is authorized to sell products throughout the USA, MENA, and other countries that recognize the authority of the CE certification.